Connecting and powering the world’s healthcare data through diversity patient analytics
Health Research Data Continuum
Rubix LS is a leader in consulting data analytics for underrepresented populations within health research
Countries Supported
Diseases Supported
Enabling Patient Inclusivity
for Better Health Outcomes
Through our work within infectious and rare disease, we’re advancing population health by delivering analytics to drive effective and inclusive outcomes through:
Environmental
Understanding environmental causes of disease
Biorepository
Targeting patient samples for study analysis
Early Discovery
Pharmaco-analytics for targeted therapies
Pre-clinical
Animal model optimization for robust clinical studies
Clinical
Programs to enhance patient trust and engagement
Post-market
Continuous support analytics for efficacy
Explore Rubix LS
Learn what powers us to change the world of healthcare
Our Story
We are made up of who we serve
Our Mission
Harnessing access of treatment for patients
Our Values
Solving the problems that matter
Innovation and Excellence
Harnessing the power of data and digital health to get closer to patient clinical research equity
1
Using the power of AI, quantum, ML, and NLP to characterize big data and patient trends.Â
2
From the data, design effective virtual and hybrid clinical trial models to support effective and inclusive clinical trial solutions with digital health tools and our StarSense platform, a virtual clinical trial platform.
3
Data aggregated from clinical trials, support and refine development for expansive therapeutic support for multiple patient demographics.
With access to numerous data points on various disease settings and patients treated across our network, Rubix LS is evolving the way life science companies are using real-world data to accelerate research and generate evidence.
Consulting
Advisory and subject matter expertise to support organizational challenges
Data Analytics
We put data endpoints together to enable strategic decision-making
Government
SME’s supporting federal responses nationally and globally
Therapeutics
Our therapeutic pipeline to support our growing targeted areas.
One patient at a time
Deep scientific and research expertise in uncovering inclusive opportunities
Infectious Disease
Rare & Ultra Rare
Environmental
Oncology
![[WHITE PAPER] Therapeutic Outcomes](https://i2.wp.com/rubixls.com/wp-content/uploads/2021/07/shutterstock_1891996303.jpg?resize=400%2C250&ssl=1)
[WHITE PAPER] Therapeutic Outcomes
Health disparities exist among specific population groups in the...
![[WHITE PAPER] Clinical Disparities in Disease Diagnosis](https://i1.wp.com/rubixls.com/wp-content/uploads/2021/05/shutterstock_1854623368.jpg?resize=400%2C250&ssl=1)
[WHITE PAPER] Clinical Disparities in Disease Diagnosis
As we overcome the patient care challenges of what COVID-19 has brought, we’re looking at how deeper clinical diagnosis disparities make therapeutic and patient centricity a challenge.
We'll share more about how we help
We will respond to your inquiry to kick off a discussion.